Lixte Biotechnology Warrants
LIXTW
LIXTW was delisted on the 26th of November, 2025.
4 hedge funds and large institutions have $3.41K invested in Lixte Biotechnology Warrants in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
41% more capital invested
Capital invested by funds: $2.41K → $3.41K (+$993)
33% more funds holding
Funds holding: 3 → 4 (+1)
0.16% more ownership
Funds ownership: 2.86% → 3.02% (+0.16%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$242 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$7 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Warberg Asset Management
Winnetka,
Illinois
| $2.05K | – | – | – |
|
|
CS
2
Clear Street
New York
| $1.16K | -$7 | -100 | -0.4% |
|
|
3
UBS Group
Zurich,
Switzerland
| $193 | +$242 | +3,643 | +1,735% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $5 | +$7 | +100 | New |
|
LIXTW Hedge Fund Activity: Q1 2024 in Review
4 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Lixte Biotechnology Warrants (LIXTW) for Q1 2024, worth a combined $3.41K — up 41% from $2.41K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LIXTW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $242. The largest seller was Clear Street, cutting an estimated $7.
- 4 institutional investors held Lixte Biotechnology Warrants (LIXTW) as of Q1 2024, up from 3 in Q4 2023.
- Funds reported $3.41K of Lixte Biotechnology Warrants stock for Q1 2024, up 41% quarter-over-quarter.
- 1 fund opened new Lixte Biotechnology Warrants positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest Lixte Biotechnology Warrants buyer in Q1 2024 was UBS Group, an estimated $242 added.
- The largest Lixte Biotechnology Warrants seller in Q1 2024 was Clear Street, an estimated $7 sold.
Based on aggregated 13F filings for Q1 2024.